COMMUNIQUÉS West-GlobeNewswire

Celldex Therapeutics Presents Landmark 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV 2024

25/09/2024 - 16:45

- 71% of patients (150 mg Q4W) achieved complete response at Week 52 - - Rapid, profound and durable improvement in UAS7 as early as Week 1 with a deepening of response over 52 weeks - - Robust improvement across [...]

Boehringer Ingelheim expands cancer research at its Vienna site

25/09/2024 - 16:45

Inauguration of Angelika Amon research building in Vienna Sustainable research building at a cost of EUR 60 million offers modern office and laboratory space Over the past five years, Boehringer’s capital investments [...]

LifeLabs to Honour National Day for Truth and Reconciliation with Educational Initiatives and Community Support

25/09/2024 - 16:19

Vancouver, B.C., Toronto, ON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- On September 30, LifeLabs will pause operations to recognize National Day for Truth and Reconciliation and Orange Shirt Day. This day honours the lost [...]

Capsa Healthcare Unveils the New Tryten P-Series: Engineering a Path to Better Care

25/09/2024 - 16:12

COLUMBUS, Ohio, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leader in purposefully designed integrated solutions, proudly announces the launch of the new Tryten P-Series tablet and monitor carts that are [...]

Spinogenix Announces Launch of a Phase 2 Clinical Trial Evaluating SPG302 for the Treatment of Schizophrenia

25/09/2024 - 16:00

Phase 2 trial is designed to evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a primary diagnosis of schizophrenia LOS ANGELES, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Spinogenix, [...]

Dallas Business Journal Recognizes USOSM COO Alisa Ulrey for Leadership

25/09/2024 - 15:47

IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Dallas Business Journal has selected U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey as a 2024 C-Suite Leaders Awards program honoree. The C- [...]

Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study

25/09/2024 - 15:15

- Patients are preselected for CDKN2A and/or CDKN2B abnormalities - - Safety and efficacy data to be reported at an upcoming oncology medical conference - BERKELEY HEIGHTS, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]

ClinicalTrials.EU platform rolled out across Europe

25/09/2024 - 15:14

LONDON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The European Clinical Trials Information Network ( ClinicalTrials.EU ) has today announced its official rollout across the continent. The patient-centric platform aims to solve [...]

Koelis Announces New Compact 3D Probe to Improve Workflow and Reprocessing

25/09/2024 - 15:07

New 3D Ultrasound Probe maximizes auto reprocessing compatibility New probe adaptor improves needle guidance for targeted biopsy and treatment GRENOBLE, France and PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

25/09/2024 - 15:02

Please see enclosed pdf. Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS

InBrain Pharma to Present Positive Results from Its DIVE-I Phase I/II Clinical Trial for Parkinson’s Disease at the Congress of Parkinson’s Disease and Movement Disorders from September 27 to October 1 in Philadelphia

25/09/2024 - 15:00

Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its Phase I/II DIVE-I clinical trial for Parkinson’s disease at the [...]

Sanner Group acquires Gilero to expand its global medical device offering

25/09/2024 - 15:00

Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the [...]

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

25/09/2024 - 15:00

VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) provides the following update: Dear Shareholders, We are [...]

GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy

25/09/2024 - 15:00

Press release GoLiver Therapeutics has been awarded €1.6m from France 2030 to progress its first biomedicine, developed from pluripotent stem cells, into the clinic for the treatment of severe liver failures. Nantes, [...]

QHSLab Secures Grant Sponsorship from a Global Leader in Consumer Health to Advance Digital Medicine Tools for Allergy Management in the Primary Care Setting

25/09/2024 - 15:00

WEST PALM BEACH, FL, Sept. 25, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

25/09/2024 - 14:55

– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory diseases – – Oral [...]

GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect Segment

25/09/2024 - 14:45

Live video webcast on Wednesday, October 2 nd at 12:00 PM ET LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an [...]

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents

25/09/2024 - 14:31

Policy update increases access for millions covered by HCSC BlueCross BlueShield policies MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on [...]

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

25/09/2024 - 14:30

JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development of orally delivered peptides, and OPKO Health, Inc. (NASDAQ: OPK) (OPKO) announced today [...]